Report overview
Prostate cancer testing refers to the tests conducted for the detection, localization, grading, and staging of prostate carcinoma. The currently established methods of prostate cancer detection include digital rectal examination (DRE), serum prostate-specific antigen (PSA) tests, and transrectal ultrasound (TRUS)-guided prostate biopsy using a systematic 12-core method.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Testing. This report contains market size and forecasts of Prostate Cancer Testing in global, including the following market information:
Global Prostate Cancer Testing Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Prostate Cancer Testing market was valued at US$ 13820 million in 2022 and is projected to reach US$ 22650 million by 2029, at a CAGR of 7.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The high prevalence rate of prostate cancer is a key factor, which is driving the global market for the prostate cancer. Prostate cancer is the second-leading cause of death in the United States. According to National Cancer Institute, it is estimated that there were around 161,360 new cases of prostate cancer and an estimated 26,730 people will die due to it. Based on these statistics, we can see that the prevalence rate of prostate cancer is increasing across the world and hence, it is driving the market.
We surveyed the Prostate Cancer Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Testing Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Prostate Cancer Testing Market Segment Percentages, by Type, 2022 (%)
PSA Tests
CTC Tests
Immunohistochemistry
PCA3 Tests
Others
Global Prostate Cancer Testing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Prostate Cancer Testing Market Segment Percentages, by Application, 2022 (%)
Hospital Associated Labs
Independent Diagnostic Laboratories
Cancer Research Institutes
Others
Global Prostate Cancer Testing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Prostate Cancer Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Prostate Cancer Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Genomic Health
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prostate Cancer Testing, market overview.
Chapter 2: Global Prostate Cancer Testing market size in revenue.
Chapter 3: Detailed analysis of Prostate Cancer Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prostate Cancer Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
